GSK completes OTC transaction with Novartis

2 March 2015 - Deborah Wilkes

Archived

GlaxoSmithKline completed its three-part transaction with Novartis – including the formation of a global consumer healthcare joint venture – on 2 March 2015. The company has also announced the return of its Alli (orlistat) weight-loss medicine to US stores after an absence of almost a year.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: